hormone therapy

• Just what the doctor ordered! It's a small country, but Switzerland's pharmaceutical industry packs a global punch with a world market share of an astonishing seven per cent. Playing home to the likes of Novartis, Roche and Serono, the country remains an important centre for the pharmaceutical industry.

...The hormone was produced from the urine of women, mainly nuns.... areas which are new territory like gene therapy or stem cell technology) requires a much longer ti...

• Swiss News
• Num. 2003, Juin 2003

• Meldungen und Bewilligungsgesuche für Tätigkeiten mit gentechnisch veränderten oder pathogenen Organismen in geschlossenen Systemen

... HER-ö2/neu for active specific immuno-therapy. A000706 27.10.01 GE Antonarakis S. E.,. Universi... of in vitro cellular assays for nuclear hormone receptor drug developement (LXR, PPAR). Since Feb....

• Bundesblatt num. 17, 30 avril 2002
• Seccion Unica

• Notifications et demandes d’autorisation pour des activités impliquant des organismes génétiquement modifiés ou pathogènes en milieu confiné

... HER-ö2/neu for active specific immuno-therapy. A000706 27.10.01 GE Antonarakis S. E.,. Universi... of in vitro cellular assays for nuclear hormone receptor drug developement (LXR, PPAR). Since Feb....

• Feuille Fédérale num. 17, 30 avril 2002
• Seccion Unica

• Notifiche e domande d'autorizzazione per attività in sistemi chiusi con organismi geneticamente modificati o patogeni

... HER-ö2/neu for active specific immuno-therapy. A000706 27.10.01 GE Antonarakis S. E.,. Universi... of in vitro cellular assays for nuclear hormone receptor drug developement (LXR, PPAR). Since Feb....

• Foglio Federale num. 17, 30 avril 2002
• Seccion Unica

• Notifiche e domande d’autorizzazione per attività in sistemi chiusi con organismi geneticamente modificati o patogeni

... d'un variant hyperglycosylé de l'hormone folliculostimulante humaine (hFSH) en cellules mam... for in vitro evaluation of suicide gene therapy based on thymdine kinase in the context of stem ce...

• Foglio Federale num. 8, 22 février 2011
• Seccion Unica

• Meldungen und Bewilligungsgesuche für Tätigkeiten mit gentechnisch veränderten oder pathogenen Organismen in geschlossenen Systemen

... d'un variant hyperglycosylé de l'hormone folliculostimulante humaine (hFSH) en cellules mam... for in vitro evaluation of suicide gene therapy based on thymdine kinase in the context of stem ce...

• Bundesblatt num. 8, 22 février 2011
• Seccion Unica

• Notifiche e domande d'autorizzazione per attività in sistemi chiusi con organismi geneticamente modificati o patogeni

... : from Molecular Mechanisms to Gene Therapy A000081 08.08.00 VD Michelle Rossier, Hôpital. d...Efficient expression of steroid hormone modulators in mammalian cells using adenoviral vec...

• Foglio Federale num. 43, 31 octobre 2000
• Seccion Unica

• Notifiche e domande d'autorizzazione per attività in sistemi chiusi con organismi geneticamente modificati o patogeni

... to encapsulation/transplantation therapy of type 1 diabetes A000319 08.05.01 ZH Peter J. Me... Growth Factor beta and Parathyroid hormone A000531 05.09.00 BS Isabelle Rauseo, Novartis. Pha...

• Foglio Federale num. 26, 3 juillet 2001
• Seccion Unica

• Notifications et demandes d’autorisation pour des activités impliquant des organismes génétiquement modifiés ou pathogènes en milieu confiné

... Molecular Mechanisms to. Gene Therapy. A000081 08.08.00 VD Michelle Rossier, Hôpital. ...Efficient expression of steroid hormone modulators in mammalian cells using adenoviral vec...

• Feuille Fédérale num. 43, 31 octobre 2000
• Seccion Unica

• Meldungen und Bewilligungsgesuche für Tätigkeiten mit gentechnisch veränderten oder pathogenen Organismen in geschlossenen Systemen

... Molecular Mechanisms to. Gene Therapy. A000081 08.08.00 VD Michelle Rossier, Hôpital. ...Efficient expression of steroid hormone modulators in mammalian cells using adenoviral vec...

• Bundesblatt num. 43, 31 octobre 2000
• Seccion Unica